Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus-Reference-Cited by-同舟云学术

Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus

Published:2014-08 Issue:2 Volume:31 Page:87-91
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Fuchs Uwe,Zittermann Armin,Ensminger Stephan M.,Schulz Uwe,Gummert Jan F.

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference35 articles.

1. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis;Ye;J Heart Lung Transplant,2009

2. Impact of different long-term maintenance immunosuppressive strategies on patients outcome after heart transplantation;Dandel;Transplant Immunol,2010

3. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate;Arora;J Heart Lung Transplant,2012

4. Mechanism of nephrotoxicity;Campistol;Transplantation,2000

5. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus;Zadrazil;Biomed Pap Med Fac Univ Palacky Repub,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists;Clinical Transplantation;2024-02

2. Impact of tacrolimus versus cyclosporin A on renal function during the first year after heart transplant;ESC Heart Failure;2020-05-23

3. Rejection: the emperor’s new clothes;Transplant International;2020-04-16

4. Renal protection strategies after heart transplantation;Clinical Transplantation;2018-01

5. Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation;Transplantation;2016-12